Unlocking the Potential of mRNA as a Tool for Immuno-Oncology Therapy Discovery and Development

Join us for an engaging webinar hosted by Telesis Bio, where we'll explore the cutting-edge realm of immuno-oncology and its therapeutic advancements. Learn how Telesis Bio's innovative BioXP instrument and custom BioXp kits are revolutionizing the field by synthesizing complex DNA and mRNA sequences more rapidly, significantly shortening the discovery phase.

Highlights of the Webinar:

• Overcoming Traditional Challenges: Discover how Telesis Bio is bypassing the limitations of traditional viral vector-based recombinant TCR gene expression, enabling the rapid construction of hundreds of candidates weekly, thus enhancing confidence in screening and lead optimization.
• Innovative mRNA Use: Learn about the direct application of mRNA for transient modulation of cellular phenotypes, facilitating quick and cost-effective candidate screening.
• Automation in Synthetic Biology: Find out how immuno-oncology researchers are utilizing Telesis Bio’s technology to automate synthetic biology, unlocking unprecedented speed and efficiency in adoptive T-cell therapies and vaccine discovery workflows.

Presenter:

David Weiss

Sr. Global Product Manager
Telesis Bio